Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial. (Q38383854)
Jump to navigation
Jump to search
scientific article published on December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial. |
scientific article published on December 2016 |
Statements
Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial (English)
Abhijit Barve
Cornelius F Waller
Miguel Hernandez-Bronchud
Jay Herson
Jinyu Yuan
Rajiv Sharma
Mark Baczkowski
Mudgal Kothekar
Subramanian Loganathan
Alexey Manikhas
Igor Bondarenko
Guzel Mukhametshina
Gia Nemsadze
Joseph D Parra
Maria Luisa T Abesamis-Tiambeng
Kakhaber Baramidze
Charuwan Akewanlop
Virote Sriuranpong
Gopichand Mamillapalli
Sirshendu Ray
Eduardo P Yanez Ruiz
Eduardo Pennella
Heritage Study Investigators